Live feed08:05:00·510dPRReleasevia QuantisnowScholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)ByQuantisnow·Wall Street's wire, on your screen.SRRK· Scholar Rock Holding CorporationHealth Care
